UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth

The Journal of immunology (1950), 2016-03, Vol.196 (5), p.2410-2423

2016

Volltextzugriff (PDF)

Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model

Scientific reports, 2019-02, Vol.9 (1), p.2855-2855, Article 2855

2019

Volltextzugriff (PDF)

Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses

PloS one, 2013-12, Vol.8 (12), p.e83765-e83765

2013

Volltextzugriff (PDF)

CD8 + T Cells Directed Against a Peptide Epitope Derived From Peptidoglycan-Associated Lipoprotein of Legionella pneumophila Confer Disease Protection

Frontiers in immunology, 2020-12, Vol.11, p.604413-604413

2020

Volltextzugriff (PDF)

B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

Human vaccines & immunotherapeutics, 2021-07, Vol.17 (7), p.1910-1922

2021

Volltextzugriff (PDF)

MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model

Vaccine, 2011-05, Vol.29 (24), p.4125-4131

Sin, Jeong-Im

2011

Volltextzugriff (PDF)

B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B

Cellular immunology, 2021-09, Vol.367, p.104394-104394, Article 104394

2021

Volltextzugriff (PDF)

Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression

Immunology, 2009-09, Vol.128 (1pt2), p.e707-e717

Sin, Jeong-Im

2009

Volltextzugriff (PDF)

Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model

DNA and cell biology, 2017-09, Vol.36 (9), p.801-811

2017

Volltextzugriff (PDF)

DNA vaccines, electroporation and their applications in cancer treatment

Human vaccines & immunotherapeutics, 2015-08, Vol.11 (8), p.1889-1900

2015

Volltextzugriff (PDF)

Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy

Clinical cancer research, 2007-01, Vol.13 (1), p.341-349

2007

Volltextzugriff (PDF)

Both antigen optimization and lysosomal targeting are required for enhanced anti‐tumour protective immunity in a human papillomavirus E7‐expressing animal tumour model

Immunology, 2005-10, Vol.116 (2), p.255-266

2005

Volltextzugriff (PDF)

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein

Clinical and Experimental Vaccine Research , 2018, 7(2), , pp.119-128

2018

Volltextzugriff (PDF)

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model

Cancer letters, 2015-01, Vol.356 (2), p.676-685

2015

Volltextzugriff (PDF)

Adoptive Transfer of Human Papillomavirus E7-specific CTL Enhances Tumor Chemoresponse Through the Perforin/Granzyme-mediated Pathway

Molecular therapy, 2009-05, Vol.17 (5), p.906-913

2009

Volltextzugriff (PDF)

Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production

Clinical and Experimental Vaccine Research , 2017, 6(2), , pp.135-145

2017

Volltextzugriff (PDF)

Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model

Vaccine, 2013-08, Vol.31 (37), p.3879-3887

2013

Volltextzugriff (PDF)

Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors

DNA and cell biology, 2018-10, Vol.37 (10), p.850-860

2018

Volltextzugriff (PDF)

Alterations of Colonic Contractility in an Interleukin-10 Knockout Mouse Model of Inflammatory Bowel Disease

Journal of neurogastroenterology and motility, 2015-01, Vol.21 (1), p.51-61

2015

Volltextzugriff (PDF)

Effect of age and stage of endometriosis on ovarian follicular loss during laparoscopic cystectomy for endometrioma

International journal of gynecology and obstetrics, 2011-08, Vol.114 (2), p.128-132

2011

Volltextzugriff (PDF)

Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

Oncotarget, 2017-04, Vol.8 (16), p.26771-26788

2017

Volltextzugriff (PDF)

Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites

Cancer letters, 2013-04, Vol.330 (2), p.190-199

2013

Volltextzugriff (PDF)

Enhancement of protective humoral (Th2) and cell‐mediated (Th1) immune responses against herpes simplex virus‐2 through co‐delivery of granulocyte‐macrophage colony‐stimulating factor expression cassettes

European journal of immunology, 1998-11, Vol.28 (11), p.3530-3540

1998

Volltextzugriff (PDF)

Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism

Human vaccines & immunotherapeutics, 2012-11, Vol.8 (11), p.1714-1721

2012

Volltextzugriff (PDF)

Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration

Journal of Gynecologic Oncology, 2012, 23(4), , pp.274-281

2012

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(94)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(58)
Animals
(45)
Female
(44)
Mice
(40)
Immunology
(32)
Humans
(25)
Mice, Inbred C57bl
(20)
Mice, Inbred Balb C
(16)
T-Lymphocytes, Cytotoxic - Immunology
(16)
Tumors
(14)
Biological And Medical Sciences
(13)
Human Papillomavirus
(13)
Vaccines, Dna - Immunology
(13)
Cervical Cancer
(12)
Original
(12)
Dna Vaccines
(11)
Genetics & Heredity
(11)
Oncology
(11)
Th1 Cells - Immunology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth

Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model

Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses

CD8 + T Cells Directed Against a Peptide Epitope Derived From Peptidoglycan-Associated Lipoprotein of Legionella pneumophila Confer Disease Protection

B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model

B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B

Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression

Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model

DNA vaccines, electroporation and their applications in cancer treatment

Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy

Both antigen optimization and lysosomal targeting are required for enhanced anti‐tumour protective immunity in a human papillomavirus E7‐expressing animal tumour model

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model

Adoptive Transfer of Human Papillomavirus E7-specific CTL Enhances Tumor Chemoresponse Through the Perforin/Granzyme-mediated Pathway

Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production

Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model

Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors

Alterations of Colonic Contractility in an Interleukin-10 Knockout Mouse Model of Inflammatory Bowel Disease

Effect of age and stage of endometriosis on ovarian follicular loss during laparoscopic cystectomy for endometrioma

Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites

Enhancement of protective humoral (Th2) and cell‐mediated (Th1) immune responses against herpes simplex virus‐2 through co‐delivery of granulocyte‐macrophage colony‐stimulating factor expression cassettes

Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism

Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration

Suchergebnisse filtern